Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ahmet M Ulusan"'
Autor:
Roderick H. Dashwood, Eduardo Vilar, Altaf Mohammed, Shizuko Sei, Powel H. Brown, Michelle I. Savage, Trace A. Gustafson, Sabeeta Kapoor, Omer F. Yavuz, Wan Mohaiza Dashwood, Praveen Rajendran, Ahmet M. Ulusan
Figs S1-S8, Supplementary Tables 1&2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0892025818ecfd2ec74e1237a54492f4
https://doi.org/10.1158/1940-6207.22534196.v1
https://doi.org/10.1158/1940-6207.22534196.v1
Autor:
Roderick H. Dashwood, Eduardo Vilar, Altaf Mohammed, Shizuko Sei, Powel H. Brown, Michelle I. Savage, Trace A. Gustafson, Sabeeta Kapoor, Omer F. Yavuz, Wan Mohaiza Dashwood, Praveen Rajendran, Ahmet M. Ulusan
A clinical trial in patients with familial adenomatous polyposis (FAP) demonstrated that sulindac plus erlotinib (SUL+ERL) had good efficacy in the duodenum and colon, but toxicity issues raised concerns for long-term prevention. We performed a bioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dabf5ffab8784c208ef6aec0962c1dc
https://doi.org/10.1158/1940-6207.c.6547403.v1
https://doi.org/10.1158/1940-6207.c.6547403.v1
Autor:
Li Li, Ming Hu, Taijun Yin, Song Gao, Wan-Mohaiza Dashwood, Ahmet M Ulusan, Ke-He Ruan, Katherine Shatzer, Changhong Yun
Publikováno v:
Inflammation Research. 69:131-137
This study sought to evaluate short-term treatment with COX-2 inhibitors and acute changes in colonic PGE2 levels as predictors of long-term efficacy in a genetic model of colorectal cancer. Celecoxib oral suspension (40 mg/kg BID) was dosed to Apc-m
Autor:
Ying-Shiuan Chen, Laura M. Beaver, Gavin S. Johnson, Yun Huang, Deqiang Sun, Emily Ho, W. Mohaiza Dashwood, Shan Wang, Praveen Rajendran, Hon-Chiu Eastwood Leung, Nhung T. Nguyen, Ahmet M Ulusan, Roderick H. Dashwood, Kyle Chang, David A. Lieberman, Furkan U. Ertem, Jia Li, Eduardo Vilar, Li Li, Mutian Zhang, Mark T. Bedford
Publikováno v:
Cancer Research. 79:918-927
There continues to be interest in targeting epigenetic “readers, writers, and erasers” for the treatment of cancer and other pathologies. However, a mechanistic understanding is frequently lacking for the synergy observed when combining deacetyla
Autor:
Omer F. Yavuz, Powel H. Brown, Wan Mohaiza Dashwood, Praveen Rajendran, Michelle I. Savage, Roderick H. Dashwood, Ahmet M. Ulusan, Shizuko Sei, Trace A. Gustafson, Eduardo Vilar, Altaf Mohammed, Sabeeta Kapoor
Publikováno v:
Cancer prevention research (Philadelphia, Pa.), vol 14, iss 3
Cancer Prev Res (Phila)
Cancer Prev Res (Phila)
A clinical trial in patients with familial adenomatous polyposis (FAP) demonstrated that sulindac plus erlotinib (SUL+ERL) had good efficacy in the duodenum and colon, but toxicity issues raised concerns for long-term prevention. We performed a bioma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f62f7ed92c43ffaa468ef3e7464079e5
https://escholarship.org/uc/item/9mp7231d
https://escholarship.org/uc/item/9mp7231d
Autor:
Chakrapani Tripathi, Wan-Mohaiza Dashwood, Alessandro Shapiro, Altaf Mohammed, Michelle I. Savage, Eduardo Vilar Sanchez, Praveen Rajendran, Melek Demirhan, Powel H. Brown, Roderick H. Dashwood, Yunus Emre Demirhan, Ahmet M Ulusan, Shizuko Sei, Sabeeta Kapoor
Publikováno v:
American Journal of Gastroenterology. 116:S138-S138
Autor:
Changhong, Yun, Wan-Mohaiza, Dashwood, Li, Li, Taijun, Yin, Ahmet M, Ulusan, Katherine, Shatzer, Song, Gao, Ke-He, Ruan, Ming, Hu
Publikováno v:
Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 69(1)
This study sought to evaluate short-term treatment with COX-2 inhibitors and acute changes in colonic PGE2 levels as predictors of long-term efficacy in a genetic model of colorectal cancer.Celecoxib oral suspension (40 mg/kg BID) was dosed to Apc-mu
Autor:
Deqiang Sun, Hon-Chiu Eastwood Leung, Gavin S. Johnson, Shan Wang, Roderick H. Dashwood, Ahmet M Ulusan, Kyle Chang, W. Mohaiza Dashwood, Mark T. Bedford, Ying-Shiuan Chen, Mutian Zhang, Nhung T. Nguyen, Praveen Rajendran, Eduardo Vilar, Laura M. Beaver, Yun Huang, Li Li, Emily Ho, David A. Lieberman, Furkan U. Ertem
Publikováno v:
Cancer Research. 79:2614-2614
There continues to be interest in targeting epigenetic ‘readers, writers and erasers’ for the treatment of cancer and other pathologies. A mechanistic understanding is frequently lacking, however, for the synergy observed when combining deacetyla